Avgui Charalambous

403 total citations
18 papers, 341 citations indexed

About

Avgui Charalambous is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Avgui Charalambous has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Avgui Charalambous's work include Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Plant biochemistry and biosynthesis (4 papers). Avgui Charalambous is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Plant biochemistry and biosynthesis (4 papers). Avgui Charalambous collaborates with scholars based in United States and Greece. Avgui Charalambous's co-authors include Alexandros Makriyannis, Gilbert Marciniak, Billy R. Martin, David M. Compton, De‐Ping Yang, Guo Yan, Leo G. Herbette, Alexandros Makriyannis, Thomas Mavromoustakos and Anna Tavridou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Avgui Charalambous

18 papers receiving 337 citations

Peers

Avgui Charalambous
Paul Westwood United Kingdom
Silvano Sanchini United States
Richard Goodwin United Kingdom
Thuy Nguyen United States
Spiro Pavlopoulos United States
Lorraine McIntosh United Kingdom
Gillian Goodwin United Kingdom
Phillip M. Cowley United Kingdom
Frances M. Casiano United States
Ritesh Tichkule United States
Paul Westwood United Kingdom
Avgui Charalambous
Citations per year, relative to Avgui Charalambous Avgui Charalambous (= 1×) peers Paul Westwood

Countries citing papers authored by Avgui Charalambous

Since Specialization
Citations

This map shows the geographic impact of Avgui Charalambous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avgui Charalambous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avgui Charalambous more than expected).

Fields of papers citing papers by Avgui Charalambous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avgui Charalambous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avgui Charalambous. The network helps show where Avgui Charalambous may publish in the future.

Co-authorship network of co-authors of Avgui Charalambous

This figure shows the co-authorship network connecting the top 25 collaborators of Avgui Charalambous. A scholar is included among the top collaborators of Avgui Charalambous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avgui Charalambous. Avgui Charalambous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tavridou, Anna, Loukas Kaklamanis, Αpostolos Papalois, et al.. (2008). Antiatherosclerotic Properties of EP2302, a Novel Squalene Synthase Inhibitor, in the Cholesterol-fed Rabbit. Journal of Cardiovascular Pharmacology. 51(6). 573–580. 6 indexed citations
2.
3.
Tavridou, Anna, Loukas Kaklamanis, Αpostolos Papalois, et al.. (2007). EP2306 [2-(4-Biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], A Novel Squalene Synthase Inhibitor, Reduces Atherosclerosis in the Cholesterol-Fed Rabbit. Journal of Pharmacology and Experimental Therapeutics. 323(3). 794–804. 18 indexed citations
4.
Tavridou, Anna, Loukas Kaklamanis, Angeliki P. Kourounakis, et al.. (2006). Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis. European Journal of Pharmacology. 535(1-3). 34–42. 28 indexed citations
5.
Nikas, Spyros P., Jolanta Grzybowska, Demetris P. Papahatjis, et al.. (2004). The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model. The AAPS Journal. 6(4). 23–35. 23 indexed citations
6.
Kilbourn, Michael R., Avgui Charalambous, Kirk A. Frey, et al.. (1997). Intrastriatal Neurotoxin Injections Reduce in Vitro and in Vivo Binding of Radiolabeled Rotenoids to Mitochondrial Complex I. Journal of Cerebral Blood Flow & Metabolism. 17(3). 265–272. 12 indexed citations
7.
Charalambous, Avgui, et al.. (1995). Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity. Nuclear Medicine and Biology. 22(1). 65–69. 9 indexed citations
8.
9.
Charalambous, Avgui, et al.. (1994). Synthesis of (N‐[11C]methyl)Y‐29794, a competitive inhibitor of prolyl endopeptidase. Journal of Labelled Compounds and Radiopharmaceuticals. 34(6). 499–503. 2 indexed citations
10.
Martin, Billy R., David M. Compton, Simon F. Semus, et al.. (1993). Pharmacological evaluation of iodo and nitro analogs of Δ8-THC and Δ9-THC. Pharmacology Biochemistry and Behavior. 46(2). 295–301. 31 indexed citations
11.
Charalambous, Avgui, Guo Yan, A­llyn C. Howlett, et al.. (1992). 5'-Azido-.DELTA.8-THC: a novel photoaffinity label for the cannabinoid receptor. Journal of Medicinal Chemistry. 35(16). 3076–3079. 35 indexed citations
12.
Charalambous, Avgui, Gilbert Marciniak, Chyng‐Yann Shiue, et al.. (1991). PET studies in the primate brain and biodistribution in mice using (−)-5′-18F-Δ8-THC. Pharmacology Biochemistry and Behavior. 40(3). 503–507. 36 indexed citations
13.
Yang, De‐Ping, et al.. (1991). Solid state 2H-NMR as a method for determining the orientation of cannabinoid analogs in membranes. Pharmacology Biochemistry and Behavior. 40(3). 553–557. 18 indexed citations
14.
Burstein, Sumner, Charlene A. Audette, Avgui Charalambous, et al.. (1991). Detection of cannabinoid receptors by photoaffinity labelling. Biochemical and Biophysical Research Communications. 176(1). 492–497. 15 indexed citations
15.
Charalambous, Avgui, S. Lin, Gilbert Marciniak, et al.. (1991). Pharmacological evaluation of halogenated Δ8-THC analogs. Pharmacology Biochemistry and Behavior. 40(3). 509–512. 29 indexed citations
16.
Mavromoustakos, Thomas, De‐Ping Yang, Avgui Charalambous, Leo G. Herbette, & Alexandros Makriyannis. (1990). Study of the topography of cannabinoids in model membranes using X-ray diffraction. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1024(2). 336–344. 42 indexed citations
17.
Schyf, Cornelis J. Van der, et al.. (1988). Synthesis of deuterium labeled cannabinoids. Journal of Labelled Compounds and Radiopharmaceuticals. 25(1). 73–82. 15 indexed citations
18.
Charalambous, Avgui, et al.. (1987). Specific deuteration of phenols and aromatic ethers using boron trifluoride and deuterium oxide. Journal of Labelled Compounds and Radiopharmaceuticals. 24(12). 1479–1482. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Westwood Breakdown of academic impact, for papers by Silvano Sanchini Breakdown of academic impact, for papers by Richard Goodwin Breakdown of academic impact, for papers by Thuy Nguyen Breakdown of academic impact, for papers by Spiro Pavlopoulos Breakdown of academic impact, for papers by Lorraine McIntosh Breakdown of academic impact, for papers by Gillian Goodwin Breakdown of academic impact, for papers by Phillip M. Cowley Breakdown of academic impact, for papers by Frances M. Casiano Breakdown of academic impact, for papers by Ritesh Tichkule
Rankless by CCL
2026